Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | AP521 is an agonist of the human 5-HT1A receptor (IC50: 94 nM). |
In vitro | AP521 is an agonist of human 5-HT1A receptor (IC50s: 135, 94, 254, 5530, 418, 422 and 198 nM for 5-HT1A (rat), 5-HT1A (human), 5-HT1B (rat), 5-HT1B (human), 5-HT1D (human), 5-HT5a (human) and 5-HT7 (rat)). AP521 also decreases the forskolin-induced cAMP accumulation from 10 nM to 10 μM. |
In vivo | AP521, at dosages ranging from 0.5 to 10 mg/kg, notably enhances shock acceptances and, when orally administered at 3 and 10 mg/kg, substantially reduces freezing time. Furthermore, it doubles the duration spent on the open arms compared to the vehicle-treated group, evidencing an anxiolytic-like effect that seems dose-dependent [F(3, 36)=4.21, P<0.05 for AP521]. At a concentration of 10 mg/kg, AP521 significantly boosts the extracellular 5-HT level in the medial prefrontal cortex (mPFC) from 0.5 to 1 hour post-administration. While a 3 mg/kg dose of AP521 suggests a potential increase in the extracellular 5-HT level, this rise is statistically insignificant. |
Molecular Weight | 402.89 |
Formula | C20H19ClN2O3S |
Cas No. | 151227-08-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.